Literature DB >> 10700334

Elevated plasma levels of neuropeptide Y in female fibromyalgia patients.

.   

Abstract

Neuropeptide Y(NPY) co-exists with norepinephrine in the sympathetic nervous system, and NPY may represent the sympathetic-neuronal output. Fibromyalgia syndrome (FMS) patients have perturbations in the hypothalmic-pituitary-adrenal (HPA) axis and in the sympathetic stress axis as well. As opioid peptides, monoamines and sex steroids are integrated in the regulation of stress, it is interesting to further explore the role of NPY in FMS patients, as they show many symptoms that are related to perturbations of those systems.In this study, plasma NPY levels were assessed in subgroups of FMS patients: cyclic (regular menstrual cycles), non-cyclic (post-menopausal), depressed and non-depressed patients. In order to examine whether pain and other symptoms seen in FMS patients are correlated to the NPY levels, the patients were also registering 15 different symptoms daily during 28 days. Sex and age-matched healthy controls were recruited for comparisons. Non-parametric tests were used for the statistical analyses.The results showed that the NPY levels were significantly elevated in the patients compared to the controls. In the luteal phase of the cyclic patients, the levels of the peptide were higher than in the corresponding controls. For the non-cyclic patients, there was a positive correlation between physical symptoms and NPY levels, however, pain per se did not reach the significant level of correlation. The non-depressed patients had the same levels of NPY as the depressed FMS patients, who also had a positive correlation between anxiety and NPY levels.These results suggest that FMS patients have an altered activity in the NPY system, most likely due to prolonged and/or repeated stress, and that the hormonal state and time of the menstrual cycle also may be of importance in the complex pathophysiologic mechanism behind the development of FMS. Copyright 1999 European Federation of Chapters of the International Association for the Study of Pain.

Entities:  

Year:  1999        PMID: 10700334     DOI: 10.1053/eujp.1998.0097

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  11 in total

1.  Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controls.

Authors:  Jacob Nadav Ablin; Natalya Aronov; Ilan Shimon; Hannah Kanety; Clara Pariente; Valerie Aloush; Ori Elkayam; David Levartovsky
Journal:  Pain Res Manag       Date:  2012 Mar-Apr       Impact factor: 3.037

Review 2.  Evidence of involvement of central neural mechanisms in generating fibromyalgia pain.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

3.  Stress biomarkers' associations to pain in the neck, shoulder and back in healthy media workers: 12-month prospective follow-up.

Authors:  Elisabet Schell; Tores Theorell; Dan Hasson; Bengt Arnetz; Helena Saraste
Journal:  Eur Spine J       Date:  2007-12-13       Impact factor: 3.134

Review 4.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 5.  Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update.

Authors:  Rosalba Siracusa; Rosanna Di Paola; Salvatore Cuzzocrea; Daniela Impellizzeri
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

6.  Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides.

Authors:  Jan L Bjersing; Mats Dehlin; Malin Erlandsson; Maria I Bokarewa; Kaisa Mannerkorpi
Journal:  Arthritis Res Ther       Date:  2012-07-09       Impact factor: 5.156

7.  Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Authors:  Enrico Bellato; Eleonora Marini; Filippo Castoldi; Nicola Barbasetti; Lorenzo Mattei; Davide Edoardo Bonasia; Davide Blonna
Journal:  Pain Res Treat       Date:  2012-11-04

8.  Factors explaining variance in perceived pain in women with fibromyalgia.

Authors:  Eva Albertsen Malt; Snorri Olafsson; Anders Lund; Holger Ursin
Journal:  BMC Musculoskelet Disord       Date:  2002-04-25       Impact factor: 2.362

9.  Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin?

Authors:  Jan L Bjersing; Malin Erlandsson; Maria I Bokarewa; Kaisa Mannerkorpi
Journal:  Arthritis Res Ther       Date:  2013-02-27       Impact factor: 5.156

10.  Smoking is associated with reduced leptin and neuropeptide Y levels and higher pain experience in patients with fibromyalgia.

Authors:  Maria I Bokarewa; Malin C Erlandsson; Jan Bjersing; Mats Dehlin; Kaisa Mannerkorpi
Journal:  Mediators Inflamm       Date:  2014-08-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.